This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,295.54 firm fixed-price delivery order is for Ozempic 0.25-0.5 mg/dose pens and has a completion date of November 15, 2024.
The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, which runs through November 2026, enables efficient government procurement of essential medications, vaccines, and medical commodities across multiple therapeutic areas.
The contract award was not designated with any set-aside requirements, indicating open competition.
Generated 2/13/25, 9:03 AM